Ukuqonda i-Colon Cancer Survival Rates Ungazisa izigqibo zakho malunga nokunyamekela
Izinga lomdlavuza womhlaza weColon zithintela kwiimeko eziliqela, ngokubanzi kwisigaba sesifo. Uninzi lwamanqanaba omhlaza wekoloni luya kunyangwa ngenjongo yokuphilisa ngokupheleleyo. Oogqirha banethemba lokunyanga umdlavuza wesiqalo esisekuqaleni kwendlela eqinisekisa ukuba umntu uhlala ekhululekile kuloo mhlaza ngenxa yobomi bakhe bonke. Kamva isigaba somdlavuza wekolon siba nemingcipheko ebalulekileyo.
Uhlobo Luni Lokusinda Kweminyaka emi-5?
Usenokuba ulivile eli gama kwiofisi yakho ugqirha okanye kulabo bafunyanwe. Umlinganiselo weminyaka emihlanu wokusinda ngumyinge wabantu abaxilongwa ngomhlaza abasaphila ubuncinane iminyaka emi-5 emva kokuxilongwa kwabo okokuqala.
Ekuqaleni kwinqanaba lomdlavuza ophethwe ngokulindela ukunyanga okupheleleyo, umlinganiselo wonyaka wokuphila oma-5 usuke uthathwa njengengongoma apho umntu "ephuma emithini."
Emva komakhweba weminyaka emi-5, kungase kube lula ukuba umdlavuza ubuyele. Olunye uphando lubonisa ukuba abanye abantu kufuneka balandelwe ngokusondeleyo ukuya kwiminyaka eyi-10 emva kokuxilongwa. Oku kulandelelwano olude luya kuqinisekisa ukuba nayiphi na umhlaza we-recurrences ubanjwe ekuqaleni.
Kutheni i-5-Year Survival Rates iyanceda?
Izinga lokusinda zingasetyenzwa oogqirha njengendlela yokuxoxa ngesigxina somntu - isikolo esilindelekileyo sesifo. Ngokomzekelo, xa umdlavuza wekoloni ubanjwe kusasa, ngaphambi kokuba usasaze ngaphaya kwekholoni, ukuhlaziya isilungileyo.
Uphilo olupheleleyo, okwenene, injongo.
Ngaba Ufanele Ukhangele i-5-Year Survival Rates kwi-Stage yakho yeCaron Cancer?
Abanye abantu bafuna ukwazi amazinga okusinda kwabanye abanomdlavuza wekolon ofana nawo. Abanye abantu abanakho ukufuna ukwazi amazinga okusinda kuwo onke. Bangavakalelwa kukuba kunzima okanye baqhelanise ukwazi ipesenti yabantu abanomdlavuza ofana nabo abahlala okanye bafe ngexesha elithile.
Ngaphambi kokuba ufunde, cingisisa ngokungakhathaliseki ukuba ufuna ukwazi inani leminyaka eli-5 lokusinda kwisigaba sakho somhlaza wekoloni. Ukuba iinombolo zokusinda azikho phezulu njengokuba wawubethemba, kunokukhathazeka kakhulu ukuba wazi.
Abanye abantu bafumana ezi manani ukuba zikhuthaze, nangona ukuba izinga lokusinda liphantsi kwinqanaba lomdlavuza wekoloni. Abanye abantu baziva beqinileyo ekujoliseni "ukubetha iingxaki." Kufuneka ucinge ngoluhlobo lomntu onjani. Ngaba la manani aya kunceda okanye axinzelele kuwe?
Iminyaka eyi-5 yokuPhuphuma kweMali ayikho umfanekiso opheleleyo
Ukuza kuma-5 ama-survival rates, iingcali zezempilo kufuneka zifunde abantu abaye baphathwa ngomhlaza wabo ubuncinane iminyaka emi-5 edlulileyo. Ionyango zomhlaza zeColon zitshintshile kwaye ziyaqhubeka ziguquka ngokukhawuleza.
Ezinye unyango ezisetyenziswayo ngoku, njengezonyango ezijoliswe kuzo , azifumanekanga kwiminyaka emihlanu edlulileyo. Kwakhona khumbula ukuba amazinga okuphila angabandakanya abantu abafumene ukuba banomdlavuza wekolon, kodwa ngubani owafa ngenxa yezizathu ezingekho komhlaza.
Oku kuthetha ukuba u- 5-yearly rates rates will look look worse than what your 5 years of survival rate is .
Kubalulekile ukukhumbula ukuba amazinga okuphila aqikelelwa. Umlinganiselo wokusinda iminyaka emi-5 awunakuze wachaze oko kuya kwenzeka kwimeko nawuphi na umntu.
Ezinye izinto, ezifana nendlela umdlavuza uphendula ngayo kunyango kunye ne-genetics yamaseli omhlaza, kuya kubachaphazela amathuba okuphila.
Ukuba uthatha isigqibo sokufunda malunga neminyaka emihlanu yokusinda kwinqanaba lakho lomhlaza wekolon, qi niqiniseke ukuba uxoxe ngezinto ozifundayo nodokotela wakho. Unokukunceda uqonde ukuba la manani angasebenza njani kwiimeko zakho ezithile.
Iminyaka emi-5 yokuSindiswa kweeNqanaba ngeCandelo leCaron Cancer
Iinkqubo ezahlukeneyo zisetyenziselwa ukubeka umdlavuza wekoloni. Inkqubo yesiteji esisetyenziswayo inokuchaphazela indlela i-5-year survival rates ijonge ngayo.
Iirhafu zokusindisa ezipapashwe yi-American Cancer Society (ACS) zibonakala ziphantsi kunezo zidweliswe kwezinye iindawo.
Oku kungakho ngenxa yokuba amazinga e-ACS "ahlawulelwa amazinga." Oku kuthetha ukuba baquka abantu abafayo ngenxa yezifo ezingahambelani nomhlaza kunye neemeko emva kokuxilongwa, ezifana nesifo senhliziyo.
Iminyaka emi-5 yokuPhuphuma kweMali epapashwe ngu-ACS
- Isigaba I : 74%
- Isigaba IIA : 67%
- Isigaba IIB : 59%
- Isigaba IIC : 37%
- Isigaba IIIA : 73%
- Isigaba IIIB : 46%
- Isigaba IIIC : 28%
- Isigaba IV : 6%
Iiminyaka ezi-5 zokusinda kweeNkxaso ngokusekelwe kwiKomidi edibeneyo yaseMelika kwiCarcer (AJCC) I-6th Edition I-Colon Can Staging System System
- Isigaba I : 93.2%
- Isigaba IIA : 84.7%
- Isigaba IIB : 72.2% *
- Isigaba IIIA : 83.4%
- Isigaba IIIB : 64.1%
- Isigaba IIIC : 44.3%
- Isigaba IV : 8.1%
* Izinga lokusinda kwi-IIIA yesigaba zingcono kune-IIB yesigaba, mhlawumbi ngenxa yonyango olungakumbi lwezonyana ze-III.
Imithombo:
American Cancer Society. Isikhokelo esinqununu: I-Colon ne-Rectum Cancer. Ziziphi iindleko zokusinda kwiCrorectrect Cancer ngeSiteji? Kufumaneka: Matshi, 2010. http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_What_are_the_survival_asta_for_colorectal_cancer.asp
UOConnell JB, Maggard MA, Ko CY. http://jnci.oxfordjournals.org/cgi/content/full/96/19/142 "Iikholeji zokuKhusela iCaron nge-New Joint Committee yaseMerika kwiCancer Sixth Edition." Umbhalo weSizwe weSizwe weCancer Institute 2004 96: 1420-1425.